Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (9): 874-878.doi: 10.3969/j.issn.1000-6621.2021.09.004
Special Issue: 标准、共识、指南
• Guideline·Standard·Consensus • Previous Articles Next Articles
Chinese Antituberculosis Association
Received:
2021-07-27
Online:
2021-09-10
Published:
2021-09-07
Chinese Antituberculosis Association. Expert consensus on detection and preventive treatment of latent tuberculosis infection in high-risk population[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 874-878. doi: 10.3969/j.issn.1000-6621.2021.09.004
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.09.004
[1] |
Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M.tuberculosis? A TBNET consensus statement. Eur Respir J, 2009, 33(5):956-973. doi: 10.1183/09031936.00120908.
doi: 10.1183/09031936.00120908 pmid: 19407047 |
[2] | World Health Organization. WHO consolidated guidelines on tuberculosis: module 1: prevention, tuberculosis preventive treatment. Geneva:World Health Organization, 2020. |
[3] | World Health Organization. Global tuberculosis report 2020. Geneva:World Health Organization, 2020. |
[4] |
Hartman-Adams H, Clark K, Juckett G. Update on latent tuberculosis infection. Am Fam Physician, 2014, 89(11):889-896.
pmid: 25077395 |
[5] |
Martinez L, Cords O, Horsburgh CR, et al. The risk of tuberculosis in children after close exposure: asystematic review and individual-participant meta-analysis. Lancet, 2020, 395(10228):973-984. doi: 10.1016/S0140-6736(20)30166-5.
doi: 10.1016/S0140-6736(20)30166-5 URL |
[6] | World Health Organization. Global tuberculosis report 2019. Geneva:World Health Organization, 2019. |
[7] |
李果, 庞先琼, 徐华, 等. 潜伏性结核感染诊治进展. 中国防痨杂志, 2021, 43(1):91-95. doi: 10.3969/j.issn.1000-6621.2021.01.017.
doi: 10.3969/j.issn.1000-6621.2021.01.017 |
[8] | 成诗明, 王国治, 王黎霞, 等. 结核菌素皮肤试验使用指导手册. 北京: 人民卫生出版社, 2014. |
[9] |
Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet, 2000, 356(9235):1099-1104. doi: 10.1016/S0140-6736(00)02742-2.
doi: 10.1016/S0140-6736(00)02742-2 pmid: 11009160 |
[10] |
Edwards A, Gao Y, Allan RN, et al. Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis. Thorax, 2017, 72(10):946-949. doi: 10.1136/thoraxjnl-2016-209397.
doi: 10.1136/thoraxjnl-2016-209397 URL |
[11] |
中国防痨协会, 中国防痨协会学校与儿童结核病防治专业分会, 《中国防痨杂志》编辑委员会. 重组结核杆菌融合蛋白(EC)临床应用专家共识. 中国防痨杂志, 2020, 42(8):761-768. doi: 10.3969/j.issn.1000-6621.2020.08.001.
doi: 10.3969/j.issn.1000-6621.2020.08.001 |
[12] | 卢水华, 陆伟. 新型结核菌素皮肤试验使用手册. 北京: 人民卫生出版社, 2021. |
[13] |
何翼君, 张浩然, 辛赫男, 等. 结核菌素皮肤试验的应用及其优化. 中国防痨杂志, 2021, 43(3):204-210. doi: 10.3969/j.issn.1000-6621.2021.03.003.
doi: 10.3969/j.issn.1000-6621.2021.03.003 |
[14] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09. |
[15] |
Aggerbeck H, Ruhwald M, Hoff ST, et al. Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial. Int J Tuberc Lung Dis, 2019, 23(1):38-44. doi: 10.5588/ijtld.18.0137.
doi: 10.5588/ijtld.18.0137 pmid: 30572979 |
[16] |
Abubakar I, Jackson C, Rangaka MX. C-Tb: a latent tuberculosis skin test for the 21st century? Lancet Respir Med, 2017, 5(4):236-237. doi: 10.1016/S2213-2600(17)30012-7.
doi: 10.1016/S2213-2600(17)30012-7 URL |
[17] |
Starshinova A, Dovgalyk I, Malkova A, et al. Recombinant tuberculosis allergen (Diaskintest®) in tuberculosis diagnostic in Russia (meta-analysis). Int J Mycobacteriol, 2020, 9(4):335-346. doi: 10.4103/ijmy.ijmy_131_20.
doi: 10.4103/ijmy.ijmy_131_20 pmid: 33323648 |
[18] |
都伟欣, 韦芬, 卢锦标, 等. 冻干重组结核杆菌融合蛋白(EC)原液效力评价用国家参考品的初步建立. 中国防痨杂志, 2020, 42(8):826-831. doi: 10.3969/j.issn.1000-6621.2020.08.009.
doi: 10.3969/j.issn.1000-6621.2020.08.009 |
[19] |
张凯, 沈小兵, 陶立峰, 等. 重组结核杆菌融合蛋白(EC)产品质量标准的建立. 中国防痨杂志, 2020, 42(8):814-820. doi: 10.3969/j.issn.1000-6621.2020.08.007.
doi: 10.3969/j.issn.1000-6621.2020.08.007 |
[20] |
张凯, 陶立峰, 韦芬, 等. 重组结核杆菌融合蛋白(EC)的免疫特性和临床前安全性研究. 中国防痨杂志, 2020, 42(8):807-813. doi: 10.3969/j.issn.1000-6621.2020.08.006.
doi: 10.3969/j.issn.1000-6621.2020.08.006 |
[21] | 中华人民共和国国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020年版)的通知. 国卫办疾控函〔2020〕279号. 2020-04-02. |
[22] | World Health Organization. WHO guidelines on tuberculosis infection prevention and control: 2019 update. Geneva:World Health Organization, 2019. |
[23] |
刘二勇, 成诗明, 赖钰基, 等. 结核病预防性治疗研究进展. 中国防痨杂志, 2014, 36(1):59-63. doi: 10.3969/j.issn.1000-6621.2014.01.013.
doi: 10.3969/j.issn.1000-6621.2014.01.013 |
[24] |
艾静文, 阮巧玲, 张文宏. 结核分枝杆菌潜伏感染预防性治疗的进展. 中国防痨杂志, 2015, 37(1):80-85. doi: 10.3969/j.issn.1000-6621.2015.01.015.
doi: 10.3969/j.issn.1000-6621.2015.01.015 |
[25] | International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ, 1982, 60(4):555-564. |
[26] | World Health Organization. Global tuberculosis report 2018. Geneva:World Health Organization, 2018. |
[27] |
Mohammadzadeh R, Ghazvini K, Farsiani H, et al. Mycobacterium tuberculosis extracellular vesicles: exploitation for vaccine technology and diagnostic methods. Crit Rev Microbiol, 2021, 47(1):13-33. doi: 10.1080/1040841X.2020.1830749.
doi: 10.1080/1040841X.2020.1830749 pmid: 33044878 |
[28] |
Myllymäki H, Niskanen M, Luukinen H, et al. Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish. Dis Model Mech, 2018, 11(3):dmm033175. doi: 10.1242/dmm.033175.
doi: 10.1242/dmm.033175 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[4] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[5] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[6] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[7] | Senior Department of Tuberculosis, the 8th Medical Center of Chinese PLA General Hospital , Editorial Board of Chinese Journal of Antituberculosis , Basic and Clinical Speciality Committees of Tuberculosis Control Branch of China International Exchange , Promotive Association for Medical and Health Care . Expert consensus on multidisciplinary diagnosis and treatment of tuberculous peritonitis [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 243-257. |
[8] | Duan Hongfei, Tao Yong. Interpretation of social organization standard of Diagnosis Specification of Intraocular Tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 258-261. |
[9] | Jia Hui, Jing Hui, Ling Xiaojie, Wang Yan, Li Xuezheng. The diagnostic value of GeneXpert MTB/RIF Ultra in detecting sputum samples for newly diagnosed pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 298-304. |
[10] | Shi Yuru, Gu Dejian, Wu Jing, Liu Ting, Qin Linghan, Yue Li, Qi Yingjie. Diagnostic value of probe capture-based targeted next-generation sequencing and metagenomic next-generation sequencing for detecting Mycobacterium tuberculosis in bronchoalveolar lavage fluid [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 305-311. |
[11] | Huang Misun, Wu Yaning, Li Guilian, Liu Haican. Research advances of Mycobacterium tuberculosis enrichment technology [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373. |
[12] | Yang Ziyi, Chen Suting. Research progress on bedaquiline resistance and drug resistance diagnosis [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 374-379. |
[13] | Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao. Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163. |
[14] | Qiu Yong, Quan Zhuo, Qu Rong, Tian Fajun, Li Meng, Wang Gengsheng, Wang Ya, Guo Mingcheng, Gao Qian. Evaluation of different tuberculosis diagnostic tools for detecting patients in a primary-level clinic in rural China: a real-world retrospective study [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 181-188. |
[15] | Expert Consensus on the Diagnosis and Treatment of Spinal Tuberculosis Combined with HIV/AIDS Patients Group, Combined with HIV/AIDS Patients Group Chinese Antituberculosis Association, Chinese Antituberculosis Association of STD and AIDS Prevention and Control, the Western China Bone Tuberculosis Alliance, the North China Bone the North China Bone. Expert consensus on diagnosis and treatment of spinal tuberculosis with HIV/AIDS (2nd Edition) [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 1-11. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||